Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Wallis

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Gut|November 1, 1989
RNA editing: a novel mechanism for regulating lipid transport from the intestineJ Scott, S C Wallis, M S Davies, et al.
Anaesthesia and Intensive Care|July 3, 2018
Optimised dosing of vancomycin in critically ill Indigenous Australian patients with severe sepsisD Tsai, P C Stewart, S Hewagama, et al.
Cell|September 11, 1987
A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestineL M Powell, S C Wallis, R J Pease, et al.
Biochemical and Biophysical Research Communications|May 14, 1986
There are two gene sequences for human apolipoprotein CI (apo CI) on chromosome 19, one of which is 4 kb from the gene for apo EP J Davison, P Norton, S C Wallis, et al.
Journal of Pharmaceutical Sciences|August 1, 1996
Interaction of norfloxacin with divalent and trivalent pharmaceutical cations. In vitro complexation and in vivo pharmacokinetic studies in the dogS C Wallis, B G Charles, L R Gahan, et al.
British Journal of Anaesthesia|May 16, 2017
Comparative total and unbound pharmacokinetics of cefazolin administered by bolus versus continuous infusion in patients undergoing major surgery: a randomized controlled trialB I Naik, C Roger, K Ikeda, et al.
Nucleic Acids Research|September 11, 1985
The human apolipoprotein AII gene: structural organization and sites of expressionT J Knott, S C Wallis, M E Robertson, et al.
Minerva Anestesiologica|April 26, 2014
Extended versus bolus infusion of meropenem and piperacillin: a pharmacokinetic analysisJ De Waele, M Carlier, E Hoste, et al.
Antimicrobial Agents and Chemotherapy|May 19, 2010
Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltrationI Bilgrami, J A Roberts, S C Wallis, et al.
The Journal of Antimicrobial Chemotherapy|November 6, 2015
Population pharmacokinetics of linezolid in critically ill patients on renal replacement therapy: comparison of equal doses in continuous venovenous haemofiltration and continuous venovenous haemodiafiltrationC Roger, L Muller, S C Wallis, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Gut|November 1, 1989
RNA editing: a novel mechanism for regulating lipid transport from the intestineJ Scott, S C Wallis, M S Davies, et al.
Anaesthesia and Intensive Care|July 3, 2018
Optimised dosing of vancomycin in critically ill Indigenous Australian patients with severe sepsisD Tsai, P C Stewart, S Hewagama, et al.
Cell|September 11, 1987
A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestineL M Powell, S C Wallis, R J Pease, et al.
Biochemical and Biophysical Research Communications|May 14, 1986
There are two gene sequences for human apolipoprotein CI (apo CI) on chromosome 19, one of which is 4 kb from the gene for apo EP J Davison, P Norton, S C Wallis, et al.
Journal of Pharmaceutical Sciences|August 1, 1996
Interaction of norfloxacin with divalent and trivalent pharmaceutical cations. In vitro complexation and in vivo pharmacokinetic studies in the dogS C Wallis, B G Charles, L R Gahan, et al.
British Journal of Anaesthesia|May 16, 2017
Comparative total and unbound pharmacokinetics of cefazolin administered by bolus versus continuous infusion in patients undergoing major surgery: a randomized controlled trialB I Naik, C Roger, K Ikeda, et al.
Nucleic Acids Research|September 11, 1985
The human apolipoprotein AII gene: structural organization and sites of expressionT J Knott, S C Wallis, M E Robertson, et al.
Minerva Anestesiologica|April 26, 2014
Extended versus bolus infusion of meropenem and piperacillin: a pharmacokinetic analysisJ De Waele, M Carlier, E Hoste, et al.
Antimicrobial Agents and Chemotherapy|May 19, 2010
Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltrationI Bilgrami, J A Roberts, S C Wallis, et al.
The Journal of Antimicrobial Chemotherapy|November 6, 2015
Population pharmacokinetics of linezolid in critically ill patients on renal replacement therapy: comparison of equal doses in continuous venovenous haemofiltration and continuous venovenous haemodiafiltrationC Roger, L Muller, S C Wallis, et al.
Pageof 5